The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Transplantation Market Research Report 2024

Global Transplantation Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1805843

No of Pages : 74

Synopsis

Transplantation is a procedure wherein diseased or injured cells, tissues, or organs are replaced with healthy cells, tissues, or organs to restore normal functioning of the body. Donor and recipient cells, tissues, and organs should match or be compatible, or can lead to transplant rejection. The surface of the transplanted organs contains antigens, which the recipient's immune system may not adapt to. This can lead to rejection of an organ. Hence, serological and human leukocyte antigen (HLAs) tests are conducted to help identify the antigens and help in successful organ transplantation. With HLA testing, immunosuppressive drugs are provided to minimize graft rejection. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients.

The global Transplantation market was valued at US$ 65780 million in 2023 and is anticipated to reach US$ 127920 million by 2030, witnessing a CAGR of 9.8% during the forecast period 2024-2030.

The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Transplantation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transplantation.

Report Scope

The Transplantation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Transplantation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Transplantation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • AbbVie
  • Arthrex
  • Zimmer Biomet
  • Medtronic
  • Novartis
  • Stryker
  • BioLifeSolutions
  • Teva Pharmaceuticals
  • Veloxis Pharmaceuticals

Segment by Type

  • Kidney Transplantation
  • Liver Transplantation
  • Heart Transplantation
  • Lung Transplantation
  • Pancreas Transplantation

Segment by Application

  • Hospitals and Transplant Centers
  • Diagnostic Registries and Research Laboratories

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Transplantation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Transplantation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Kidney Transplantation
1.2.3 Liver Transplantation
1.2.4 Heart Transplantation
1.2.5 Lung Transplantation
1.2.6 Pancreas Transplantation
1.3 Market by Application
1.3.1 Global Transplantation Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals and Transplant Centers
1.3.3 Diagnostic Registries and Research Laboratories
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Transplantation Market Perspective (2019-2030)
2.2 Transplantation Growth Trends by Region
2.2.1 Global Transplantation Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Transplantation Historic Market Size by Region (2019-2024)
2.2.3 Transplantation Forecasted Market Size by Region (2025-2030)
2.3 Transplantation Market Dynamics
2.3.1 Transplantation Industry Trends
2.3.2 Transplantation Market Drivers
2.3.3 Transplantation Market Challenges
2.3.4 Transplantation Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Transplantation Players by Revenue
3.1.1 Global Top Transplantation Players by Revenue (2019-2024)
3.1.2 Global Transplantation Revenue Market Share by Players (2019-2024)
3.2 Global Transplantation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Transplantation Revenue
3.4 Global Transplantation Market Concentration Ratio
3.4.1 Global Transplantation Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Transplantation Revenue in 2023
3.5 Transplantation Key Players Head office and Area Served
3.6 Key Players Transplantation Product Solution and Service
3.7 Date of Enter into Transplantation Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Transplantation Breakdown Data by Type
4.1 Global Transplantation Historic Market Size by Type (2019-2024)
4.2 Global Transplantation Forecasted Market Size by Type (2025-2030)
5 Transplantation Breakdown Data by Application
5.1 Global Transplantation Historic Market Size by Application (2019-2024)
5.2 Global Transplantation Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Transplantation Market Size (2019-2030)
6.2 North America Transplantation Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Transplantation Market Size by Country (2019-2024)
6.4 North America Transplantation Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Transplantation Market Size (2019-2030)
7.2 Europe Transplantation Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Transplantation Market Size by Country (2019-2024)
7.4 Europe Transplantation Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Transplantation Market Size (2019-2030)
8.2 Asia-Pacific Transplantation Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Transplantation Market Size by Region (2019-2024)
8.4 Asia-Pacific Transplantation Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Transplantation Market Size (2019-2030)
9.2 Latin America Transplantation Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Transplantation Market Size by Country (2019-2024)
9.4 Latin America Transplantation Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Transplantation Market Size (2019-2030)
10.2 Middle East & Africa Transplantation Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Transplantation Market Size by Country (2019-2024)
10.4 Middle East & Africa Transplantation Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Transplantation Introduction
11.1.4 AbbVie Revenue in Transplantation Business (2019-2024)
11.1.5 AbbVie Recent Development
11.2 Arthrex
11.2.1 Arthrex Company Detail
11.2.2 Arthrex Business Overview
11.2.3 Arthrex Transplantation Introduction
11.2.4 Arthrex Revenue in Transplantation Business (2019-2024)
11.2.5 Arthrex Recent Development
11.3 Zimmer Biomet
11.3.1 Zimmer Biomet Company Detail
11.3.2 Zimmer Biomet Business Overview
11.3.3 Zimmer Biomet Transplantation Introduction
11.3.4 Zimmer Biomet Revenue in Transplantation Business (2019-2024)
11.3.5 Zimmer Biomet Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Detail
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Transplantation Introduction
11.4.4 Medtronic Revenue in Transplantation Business (2019-2024)
11.4.5 Medtronic Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Transplantation Introduction
11.5.4 Novartis Revenue in Transplantation Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Stryker
11.6.1 Stryker Company Detail
11.6.2 Stryker Business Overview
11.6.3 Stryker Transplantation Introduction
11.6.4 Stryker Revenue in Transplantation Business (2019-2024)
11.6.5 Stryker Recent Development
11.7 BioLifeSolutions
11.7.1 BioLifeSolutions Company Detail
11.7.2 BioLifeSolutions Business Overview
11.7.3 BioLifeSolutions Transplantation Introduction
11.7.4 BioLifeSolutions Revenue in Transplantation Business (2019-2024)
11.7.5 BioLifeSolutions Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Detail
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Transplantation Introduction
11.8.4 Teva Pharmaceuticals Revenue in Transplantation Business (2019-2024)
11.8.5 Teva Pharmaceuticals Recent Development
11.9 Veloxis Pharmaceuticals
11.9.1 Veloxis Pharmaceuticals Company Detail
11.9.2 Veloxis Pharmaceuticals Business Overview
11.9.3 Veloxis Pharmaceuticals Transplantation Introduction
11.9.4 Veloxis Pharmaceuticals Revenue in Transplantation Business (2019-2024)
11.9.5 Veloxis Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’